About Matrix metalloproteinase-20
Matrix metalloproteinase-20 (MMP20) is a protein
from Homo sapiens identified by UniProt accession
O60882, 483 residues long.
MolForge cross-references it against 0 known binders and
155 disease associations.
Target properties
| Protein name | Matrix metalloproteinase-20 |
| UniProt accession | O60882 |
| Gene | MMP20 |
| Organism | Homo sapiens |
| Length | 483 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (155)
Diseases linked to this target (Open Targets).
- Hypomaturation amelogenesis imperfecta · score 0.71
- amelogenesis imperfecta · score 0.54
- mean platelet volume · score 0.43
- recessive amelogenesis imperfecta · score 0.41
- neuroinflammatory disorder · score 0.36
- matrix metalloproteinase 7 measurement · score 0.31
- urinary metabolite measurement · score 0.31
- neuroblastoma · score 0.30
- alcohol consumption measurement · score 0.27
- wellbeing measurement · score 0.27
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O60882-F1 | alphafold | PREDICTED | 83.28 | — |
Amino-acid sequence (483 residues)
MKVLPASGLA VFLIMALKFS TAAPSLVAAS PRTWRNNYRL AQAYLDKYYT NKEGHQIGEM VARGSNSMIR KIKELQAFFG LQVTGKLDQT TMNVIKKPRC GVPDVANYRL FPGEPKWKKN TLTYRISKYT PSMSSVEVDK AVEMALQAWS SAVPLSFVRI NSGEADIMIS FENGDHGDSY PFDGPRGTLA HAFAPGEGLG GDTHFDNAEK WTMGTNGFNL FTVAAHEFGH ALGLAHSTDP SALMYPTYKY KNPYGFHLPK DDVKGIQALY GPRKVFLGKP TLPHAPHHKP SIPDLCDSSS SFDAVTMLGK ELLLFKDRIF WRRQVHLRTG IRPSTITSSF PQLMSNVDAA YEVAERGTAY FFKGPHYWIT RGFQMQGPPR TIYDFGFPRH VQQIDAAVYL REPQKTLFFV GDEYYSYDER KRKMEKDYPK NTEEEFSGVN GQIDAAVELN GYIYFFSGPK TYKYDTEKED VVSVVKSSSW IGC
Explore Matrix metalloproteinase-20 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets